Literature DB >> 30137440

Prevalence and Load of Demodex folliculorum and Demodex brevis (Acari: Demodicidae) in Patients With Chronic Blepharitis in the Province of Erzincan, Turkey.

Erhan Zeytun1, Yücel Karakurt2.   

Abstract

Chronic blepharitis is an ocular disease frequently encountered by ophthalmologists. Demodex mites can play a role in the pathogenesis of blepharitis along with bacterial agents, especially in treatment-resistant cases or recurrent cases after treatment. This study was performed to determine the prevalence and load of Demodex folliculorum (Simon) and Demodex brevis Akbulutova in chronic blepharitis patients and to assess the relationship between the prevalence and load of Demodex species and ocular symptoms. The study included 365 patients diagnosed with chronic blepharitis in clinical examination, and 175 controls without any chronic or ocular disease. In the study, two eyelashes were sampled from the lower and upper lids of the right and left eyes (a total of eight samples) of the participants. Eyelash samples were examined under a light microscope, and Demodex species were identified and counted. Demodex were detected in 79.2% (95% CI: 75-83%) of patients and 31.4% (95% CI: 24-38%) of controls in this study. D. folliculorum alone (mean: 4.96; min: 1; max: 17; P < 0.001) was detected in 72.3% of patients, in 0.7% D. brevis alone (mean: 1.00, P > 0.05), and in 27% both D. folliculorum and D. brevis (mean: 21.65; min: 2; max: 79; P < 0.001). In Demodex positive controls, only D. folliculorum (mean: 2.38; min: 1; max: 6) was detected while there was no D. brevis. Nevertheless, mean ocular symptom scores were significantly higher in Demodex positive patients than in Demodex negative patients (P < 0.001). Itching, foreign body sensation, and redness were the most common complaints in Demodex positive patients. As a result, Demodex mites were high in numbers in patients with chronic blepharitis in Erzincan. There was a positive correlation between Demodex mites and chronic blepharitis and ocular symptoms. It may be helpful to consider these findings in clinical assessment of blepharitis patients.

Entities:  

Year:  2019        PMID: 30137440     DOI: 10.1093/jme/tjy143

Source DB:  PubMed          Journal:  J Med Entomol        ISSN: 0022-2585            Impact factor:   2.278


  7 in total

Review 1.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

2.  Prevalence of Demodex folliculorum and Demodex brevis in patients with blepharitis and chalazion.

Authors:  Serife Akkucuk; Ozlem Makbule Kaya; Lokman Aslan; Talat Ozdemir; Ugur Uslu
Journal:  Int Ophthalmol       Date:  2022-10-18       Impact factor: 2.029

3.  The Prevalence of Demodex folliculorum and Demodex brevis in Cylindrical Dandruff Patients.

Authors:  Jing Zhong; Yiwei Tan; Saiqun Li; Lulu Peng; Bowen Wang; Yuqing Deng; Jin Yuan
Journal:  J Ophthalmol       Date:  2019-04-03       Impact factor: 1.909

4.  The Prevalence of Demodex Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic Sign.

Authors:  William Trattler; Paul Karpecki; Yuna Rapoport; Ehsan Sadri; Scott Schachter; Walter O Whitley; Elizabeth Yeu
Journal:  Clin Ophthalmol       Date:  2022-04-15

5.  Treatment of ocular Demodex infestation with topical ivermectin cream.

Authors:  Craig J Helm
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-21

6.  Interobserver and Intraobserver Agreements of the Detection of Demodex Infestation by in Vivo Confocal Microscopy.

Authors:  Ayse Yildiz Tas; Burak Mergen; Erdost Yildiz; Betul N Bayraktutar; Ekrem Celik; Afsun Sahin; Ceyhun Arici
Journal:  Beyoglu Eye J       Date:  2022-08-05

7.  Prevalence of Ocular Demodicosis in an Older Population and Its Association With Symptoms and Signs of Dry Eye.

Authors:  Anny Mansim Cheng; Jodi Hwang; Harrison Dermer; Anat Galor
Journal:  Cornea       Date:  2021-08-01       Impact factor: 3.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.